PD-1 Inhibitor-Induced Thyrotoxicosis Associated with Coronary Artery Spasm and Ventricular Tachycardia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD-1 Inhibitor-Induced Thyrotoxicosis Associated with Coronary Artery Spasm and Ventricular Tachycardia

Published:2022-06-21 Issue:10-11 Volume:22 Page:892-897
ISSN:1530-7905
Container-title:Cardiovascular Toxicology
language:en
Short-container-title:Cardiovasc Toxicol

Author:

Guo Kai^ORCID,Chen Mantian,Li Jinxiang

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology

Link

https://link.springer.com/content/pdf/10.1007/s12012-022-09756-4.pdf

Reference10 articles.

1. Kennedy, L. B., & Salama, A. K. S. (2020). A review of cancer immunotherapy toxicity. CA: A Cancer Journal for Clinicians, 70, 86–104. https://doi.org/10.3322/caac.21596

2. Herbst, R. S., Giaccone, G., de Marinis, F., Reinmuth, N., Vergnenegre, A., Barrios, C. H., Morise, M., Felip, E., Andric, Z., Geater, S., Özgüroğlu, M., Zou, W., Sandler, A., Enquist, I., Komatsubara, K., Deng, Y., Kuriki, H., Wen, X., McCleland, M., … Spigel, D. R. (2020). Atezolizumab for first-line treatment of PD-L1-selected patients with NSCLC. The New England Journal of Medicine, 383, 1328–1339. https://doi.org/10.1056/nejmoa1917346

3. Lee, S. Y., Yu, C. W., Choi, Y. J., Choi, R. K., Park, J. S., Lee, H. J., Kim, J. S., Jang, H. J., Jang, D. H., Chae, M. J., Shim, W. H., & Ro, Y. M. (2014). A comparison of clinical features of coronary artery spasm with and without thyrotoxicosis. Coronary Artery Disease, 25, 125–132. https://doi.org/10.1097/mca.0000000000000069

4. Inaba, H., Ariyasu, H., Iwakura, H., Kurimoto, C., Takeshima, K., Morita, S., Furuta, H., Hotomi, M., & Akamizu, T. (2021). Distinct clinical features and prognosis between persistent and temporary thyroid dysfunctions by immune-checkpoint inhibitors. Endocrine Journal, 68, 231–241.

5. Lanza, G. A., Careri, G., & Crea, F. (2011). Mechanisms of coronary artery spasm. Circulation, 124(16), 1774–1782. https://doi.org/10.1161/circulationaha.111.037283

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Camrelizumab;Reactions Weekly;2022-11-26

2. Immune Checkpoint Inhibitors Related to Cardiotoxicity;Journal of Cardiovascular Development and Disease;2022-11-03

3. Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: A Systematic Review;International Journal of Molecular Sciences;2022-09-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3